Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cardenal Herrera University
With
Hospital Miguel Servet
The aim of this study is to determine whether treatment of temporomandibular joint added to the control group treatment and drug therapy patient base is more effective than just using the control group treatment and drug therapy in patients with chronic migraine and temporomandibular disorders to reduce pain and improve the quality of life related to health of patients.
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Chronic migraine (ICHD\_III beta, 2013)
Temporomandibular disorders (RDC/TMD)
You may not be if
other neurological disease
psychiatric diseases
Physical therapy treatment in the last 6 months
dental treatment in the last 6 months
surgery or trauma in the orofacial region
Clareo Health | Effect of Treatment of Temporomandibular Joint in Patients With Chronic Migraine and Temporomandibular Disorders